SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Steve Hufnagle who wrote (1347)10/27/1999 6:06:00 PM
From: Charlie Smith  Read Replies (1) | Respond to of 1754
 
Steve:

Corneal mapping technology which permits more exact sculpting by the laser and therefore offers better potential outcomes, including 20/10 acuity. VISX is partnering with a German company on this.

Charlie



To: Steve Hufnagle who wrote (1347)10/28/1999 4:48:00 PM
From: Dennis  Read Replies (1) | Respond to of 1754
 
the "new technology" was suppose to give ANYONE better than 20/20 vision .......they said they were just starting trials and if all went well it could be on the market within a year........I don't know anything about this company , I am just telling what I saw and heard on that news report on NBC nightly news.....it sounded like it was an entirely different technology than the one they are using now.

Hope this helps.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News